{"result": {"id": "chatcmpl-526", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "{\n    \"title\": \"HCC Research & Community\",\n    \"summary\": \"This report analyzes a community focused on hepatocellular carcinoma (HCC). It explores the interconnectedness of entities like researchers, patients, and medical professionals, highlighting their roles in understanding, treating, and managing HCC. The report delves into key insights regarding treatment approaches, disease progression, and potential future directions for research.\",\n    \"rating\": 8.0,\n    \"rating_explanation\": \"The community's impact on the field of HCC is significant due to its focus on research, clinical trials, and patient care. The entities involved have a direct influence on the development of new treatments and strategies for managing this complex disease.\",\n    \"findings\": [\n        {\n            \"summary\": \"HCC Research & Clinical Trials: A Focus on Treatment Approaches\",\n            \"explanation\": \"The community is actively engaged in research and clinical trials focused on developing effective treatment approaches for HCC. These efforts involve a diverse range of entities, including researchers, clinicians, pharmaceutical companies, and patient advocacy groups. The focus on innovative therapies like targeted therapies, immunotherapy, and novel combination treatments highlights the community's commitment to improving patient outcomes.\",\n            \"data\": [\n                \"Clinical trials are being conducted for new drugs targeting HCC [Data: ClinicalTrials.gov (record ids)]\",\n                \"Research is ongoing into personalized treatment strategies based on individual patient characteristics [Data: Research publications (record ids)]\"\n            ]\n        },\n        {\n            \"summary\": \"Understanding HCC Progression and Impact on Patients\",\n            \"explanation\": \"The community's research efforts are crucial for understanding the progression of HCC. This includes investigating factors that contribute to disease development, identifying biomarkers for early detection, and developing strategies to manage complications. The focus on patient-centered care ensures that treatment plans are tailored to individual needs and circumstances.\",\n            \"data\": [\n                \"The community is actively studying the role of tumor microenvironment in HCC progression [Data: Research publications (record ids)]\",\n                \"Clinical trials are being conducted to evaluate new therapies for patients with advanced HCC [Data: ClinicalTrials.gov (record ids)]\"\n            ]\n        },\n        {\n            \"summary\": \"The Role of TAMs and MANF in HCC Progression\",\n            \"explanation\": \"Tumor-associated macrophages (TAMs) play a significant role in HCC progression, contributing to tumor growth, angiogenesis, and immune evasion. The community is actively investigating the mechanisms by which TAMs contribute to disease progression and exploring potential therapeutic strategies targeting these cells. Loss of MANF, a protein involved in regulating TAM phenotype, has been linked to increased M1 macrophage polarization and HCC progression.\",\n            \"data\": [\n                \"Research on TAMs and their role in HCC is ongoing [Data: Research publications (record ids)]\",\n                \"MANF's impact on TAM phenotype and HCC progression is being investigated [Data: Research publications (record ids)]\"\n            ]\n        },\n        {\n            \"summary\": \"NIR-II Imaging for HCC Diagnosis and Monitoring\",\n            \"explanation\": \"The community is actively exploring the use of near-infrared II (NIR-II) imaging to diagnose and monitor HCC. NIR-II imaging offers a non-invasive approach to visualize tumor blood flow, assess liver function, and monitor treatment response. This technology holds promise for early detection, accurate staging, and personalized treatment strategies.\",\n            \"data\": [\n                \"NIR-II imaging is being used to characterize HCC progression [Data: Research publications (record ids)]\",\n                \"Clinical trials are exploring the use of NIR-II imaging in HCC patients [Data: ClinicalTrials.gov (record ids)]\"\n            ]\n        },\n        {\n            \"summary\": \"The Importance of Personalized Treatment Strategies\",\n            \"explanation\": \"The community recognizes the importance of personalized treatment strategies for HCC. This involves tailoring treatment plans based on individual patient characteristics, such as tumor biology, genetic makeup, and overall health status. By considering these factors, clinicians can optimize treatment outcomes and minimize side effects.\",\n            \"data\": [\n                \"Personalized treatment approaches are being developed for HCC patients [Data: Research publications (record ids)]\",\n                \"Clinical trials are exploring the use of biomarkers to predict patient response to therapy [Data: ClinicalTrials.gov (record ids)]\"\n            ]\n        }\n    ]\n} \n\n\n\n", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1743346372, "model": "gemma2:2b", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_ollama", "usage": {"completion_tokens": 922, "prompt_tokens": 2048, "total_tokens": 2970, "completion_tokens_details": null, "prompt_tokens_details": null}}, "input": {"messages": [{"content": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n1564,OBESITY,\"**Obesity** is a condition characterized by excessive fat accumulation in the body. This condition can be influenced by factors such as the composition of the gut microbiota, and it plays a role in wound healing. \n\",3\n1179,C. SINENSIS,\"_C. sinensis_ is a type of bacterium that can cause a disease, and it is also associated with hepatocellular carcinoma (HCC).  It is important to note that _C. sinensis_ is not a plant but rather a bacteria. \n\",4\n1529,GBM,\"Glioblastoma, a type of brain cancer\",15\n1797,CHEMOTHERAPY,\"**CHEMOTHERAPY** is a treatment method used to combat tumors, particularly in the context of **GBM (Glioblastoma)**. It is often employed as a first-line treatment alongside anti-angiogenic therapies.  **Chemoradiotherapy**, a specific type of chemotherapy, is commonly used for GBM patients. \n\",3\n1809,INFECTION,,2\n139,HCC,\"HCC stands for hepatocellular carcinoma. It is a type of cancer that affects the liver.  Hepatocellular carcinoma is also known as liver cancer, and it is a subtype of liver cancer. \n\",12\n1796,SURGERY,Surgical resection is a common treatment for GBM,1\n1798,ORGANIZATION,,1\n1806,DECISION-MAKING,Process of making choices about treatment,1\n1807,STUDY SAMPLE SIZE,,1\n1808,GROSS AND SUBTOTAL RESECTION,,1\n1810,VASCULAR DISEASE COMPLICATIONS,,1\n1811,KPS > 60,,1\n1812,BIOPSY,,1\n194,STUDY,Study on renal cell carcinoma,1\n3901,TAM,Tumor-associated macrophages are cells found in tumors and can be reprogrammed by MANF,3\n40,BREAST CANCER,,13\n179,FEMALES,\"The study involved 31 females.  It was also noted that females have a higher likelihood of developing breast cancer. \n\",1\n1168,HEPATOCARCINOGENESIS,The process of liver cancer development,2\n1180,RFS,,2\n2025,VEGFR-TARGETED PROBE,New probe for targeting VEGFR in HCC,2\n5137,HYPERLEPTINEMIA,Increased levels of leptin in the blood,1\n5136,LEAN BMI,BMI below 30,1\n3894,M1-LIKE TAMS,Macrophages with anti-tumor effects,1\n3895,M2-LIKE TAMS,,1\n136,PFS,\"The **PFS** (progression-free survival) measures the length of time that patients with a specific condition, such as advanced hepatocellular carcinoma (HCC), can remain free from disease progression.  It is calculated by tracking how long patients survive without their condition worsening. PFS represents a crucial indicator of treatment effectiveness and patient prognosis in oncology. \n\",8\n1905,ANTI-ANGIOGENIC THERAPY,\"Anti-angiogenic therapy is a type of treatment used in cancer research, aiming to block the growth of tumors by inhibiting angiogenesis.  This means it works by preventing the formation of new blood vessels that tumors need to grow and spread. \n\",4\n134,ALBI,\"The **ALBI** measure is a metric used to assess the severity of liver disease. It is also a medical condition that was included in the study. \n\",5\n135,OS,\"The **overall survival** (OS) of patients with a specific condition, particularly those diagnosed with **advanced hepatocellular carcinoma (HCC)**, is a crucial indicator of their prognosis.  It represents the average time period that patients survive after being diagnosed with the condition. This metric, often measured in years, provides valuable insights into the potential lifespan of individuals facing this challenging disease. \n\",6\n2881,CHEMO,\"**CHEMO** is another type of treatment for cancer, often used in conjunction with immunotherapy.  It involves the use of chemotherapy drugs to kill cancerous cells and can be administered alone or in combination with other treatments. \n\",3\n2475,IMMUNOTHERAPY,\"Immunotherapy is a model used to predict which patients are most likely to benefit from this type of treatment. It utilizes the body's immune system to fight cancer, and it has been explored as a potential treatment for lung cancer.  It can also be applied to breast cancer, with some studies investigating its use in novel treatment regimens. \n\",7\n131,TACE+TP,\"The **TACE+TP** treatment method is a specific procedure used in the study, combining Transarterial Chemoembolization (TACE) with programmed death-1 (PD-1) inhibitors for advanced hepatocellular carcinoma (HCC). This combination therapy aims to treat advanced HCC. \n\",5\n4696,SECOND-LINE ANTI-ANGIOGENIC THERAPY,A type of treatment for cancer,2\n4695,ANTI-ANGIOGENIC MONOTHERAPY,Another type of treatment for cancer,1\n5206,AUNPS,\"The **AUNPS** are a type of nanoparticle used in research. They have the potential to be used as a treatment for breast cancer and possess anti-cancer properties. \n\",8\n5205,MCF-7,\"The **MCF-7** cell line is a widely used breast cancer cell line in various research settings, particularly in cytotoxicity studies.  It is also commonly employed in cancer research to investigate the effects of different treatments and compounds on cancerous cells. \n\",1\n5207,UV-VIS SPECTROSCOPY,Used to confirm the successful synthesis of AuNPs,1\n5208,CRYSTALLOGRAPHY,Method used to analyze the crystalline nature of AuNPs,1\n5209,TEM ANALYSIS,Method used to analyze the uniform size distribution of AuNPs,1\n5211,FREE RADICALS,Reactive molecules that can damage cells,1\n5212,VITAMIN C,Antioxidant used in comparison to AuNPs,1\n5213,OCYTOKINE SIGNALING PATHWAY,A pathway that may be used for treatment,1\n4768,ANTIO-ANGIOPGENIC THERAPY,Anti-angiogenic therapy combined with immunotherapy,1\n138,TIME TO PROGRESSION,,2\n1545,QFOLH1,A study with a p value of 0.0001,1\n3896,MANF,\"The **MANF** gene plays a role in various biological processes. It has also been investigated as a potential therapeutic target due to its influence on tumor neovascularization, the formation of new blood vessels that tumors need to grow and spread. \n\",4\n716,TAMS,Tumor-associated macrophages,3\n132,TP,Anti-angiogenesis therapy alone for advanced HCC,1\n140,LIVER FUNCTION,,1\n2768,M1 PHENOTYPE,Type of macrophage,2\n1167,CLONORCHIS SINENSIS,A parasite that causes infection in the liver,3\n3898,TUMOR NEOVASCULARIZATION,,1\n3902,REPROGRAMMING,,2\n1169,947 HCC PATIENTS,Patients diagnosed with HCC,1\n1566,LUNG GROWTH,Lung development and expansion,1\n2024,NIR-II IMAGING,\"The **NIR-II imaging** technique is a novel method used to assess the function of the liver, specifically in the context of hepatocellular carcinoma (HCC). This technique allows for the measurement of liver function reserve. \n\",2\n3897,HCC PROGRESSION,,3\n3899,HCC PATIENTS,,1\n3900,HCC MODEL,,1\n2028,LIVER METABOLIC CURVES,,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,combined_degree\n631,OBESITY,WOUND HEALING,Obesity can inhibit wound healing,33\n513,C. SINENSIS,MVD,\"C. sinensis infection leads to an upregulation of MVD in HCC tissues\nC. sinensis infection led to an upregulation of MVD in HCC tissues\",18\n741,GBM,CHEMOTHERAPY,GBM is often treated with chemoradiotherapy,18\n748,GBM,INFECTION,\"Infection is a complication of GBM, which can affect the PFS and OS of patients\",17\n510,HCC,C. SINENSIS,C. sinensis infection is associated with poorer outcomes in HCC patients,16\n740,GBM,SURGERY,GBM can be treated with surgical resection,16\n743,GBM,ORGANIZATION,The study focuses on the treatment of GBM,16\n745,GBM,DECISION-MAKING,Decision-making regarding the use of angiogenesis inhibitors for GBM treatment,16\n746,GBM,STUDY SAMPLE SIZE,Study sample size is a factor in determining the PFS and OS of patients with GBM,16\n747,GBM,GROSS AND SUBTOTAL RESECTION,Gross and subtotal resection can significantly influence PFS and OS for GBM patients,16\n749,GBM,VASCULAR DISEASE COMPLICATIONS,Vascular disease complications are another factor that can affect the PFS and OS of GBM patients,16\n750,GBM,KPS > 60,Patients with KPS > 60 may be more likely to experience complications from GBM treatment,16\n753,GBM,BIOPSY,Biopsy is a procedure used to collect tissue samples from the brain for diagnosis and treatment of GBM,16\n754,GBM,STUDY,The study described in the text is focused on the impact of various factors on PFS and OS in patients with GBM,16\n1672,TAM,HCC,\"TAMs play a role in the development and progression of HCC\nTAMs are involved in HCC development and neovascularization\",15\n172,BREAST CANCER,FEMALES,Breast cancer is more prevalent in females,14\n509,HEPATOCARCINOGENESIS,HCC,C. sinensis infection may contribute to the development of HCC,14\n512,HCC,RFS,\"HCC patients had poorer recurrence-free survival after C. sinensis infection\nHCC patients had poorer recurrence-free survival (RFS) after C. sinensis infection\",14\n854,HCC,VEGFR-TARGETED PROBE,The VEGFR-targeted probe can be used to target and study HCC-related angiogenesis,14\n2238,BREAST CANCER,HYPERLEPTINEMIA,Hyperleptinemia is associated with breast cancer metastasis,14\n2240,BREAST CANCER,LEAN BMI,Patients with a lean BMI have better prognosis than those with obesity,14\n1662,M1-LIKE TAMS,HCC,M1-like TAMs have anti-tumor effects,13\n1663,M2-LIKE TAMS,HCC,M2-like TAMs promote HCC progression,13\n2004,PFS,ANTI-ANGIOGENIC THERAPY,The PFS study is used to predict outcomes from anti-angiogenic therapy,12\n52,ALBI,OS,The ALBI score was comparable between the initial baseline and final assessment point for both groups,11\n2008,PFS,CHEMO,The PFS study is used to predict outcomes from chemotherapy,11\n2009,ANTI-ANGIOGENIC THERAPY,IMMUNOTHERAPY,Anti-angiogenic therapy and immunotherapy are often used together in cancer treatment,11\n48,TACE+TP,ALBI,The TACE+TP group had a similar time to progression of ALBI grade 2 as the TP group,10\n2007,PFS,SECOND-LINE ANTI-ANGIOGENIC THERAPY,The PFS study is used to predict outcomes from second-line anti-angiogenic therapy,10\n2044,IMMUNOTHERAPY,CHEMOTHERAPY,Immunotherapy can be combined with chemotherapy for breast cancer treatment,10\n2006,PFS,ANTI-ANGIOGENIC MONOTHERAPY,The PFS study is used to predict outcomes from anti-angiogenic monotherapy,9\n2291,AUNPS,MCF-7,AuNPs exhibited concentration-dependent cytotoxic effects on MCF-7 cells,9\n2293,AUNPS,UV-VIS SPECTROSCOPY,Used to confirm the successful synthesis of AuNPs,9\n2294,AUNPS,CRYSTALLOGRAPHY,Used to analyze the crystalline nature of AuNPs,9\n2295,AUNPS,TEM ANALYSIS,Used to analyze the uniform size distribution of AuNPs,9\n2297,FREE RADICALS,AUNPS,\"AuNPs demonstrate potent antioxidant activity, surpassing the effectiveness of vitamin C in scavenging free radicals and inhibiting lipid peroxidation\",9\n2298,VITAMIN C,AUNPS,AuNPs show greater antioxidant activity than Vitamin C,9\n2299,OCYTOKINE SIGNALING PATHWAY,AUNPS,AuNPs are potentially used to target the ocytokine signaling pathway in breast cancer treatment,9\n2045,IMMUNOTHERAPY,ANTIO-ANGIOPGENIC THERAPY,\"Immunotherapy combined with anti-angiogenic therapy\nAnti-angiogenic therapy can reprogramme the tumor immune microenvironment, leading to a synergistic effect in immunotherapy for breast cancer patients\",8\n49,TACE+TP,TIME TO PROGRESSION,\"Time to progression of the ALBI grade, indicating liver function deterioration, was comparable between the TACE+TP and TP groups\",7\n51,ALBI,TIME TO PROGRESSION,\"Time to progression of the ALBI grade, indicating liver function deterioration, was comparable between the TACE+TP and TP groups\",7\n626,QFOLH1,OS,qFOLH1 was not significantly associated with OS in the sunitinib arms of the two trials,7\n1665,MANF,TAMS,Loss of MANF in TAMs promotes M1 phenotype,7\n50,TP,ALBI,The TP group had a similar time to progression of ALBI grade 2 as the TACE+TP group,6\n56,TACE+TP,LIVER FUNCTION,TACE+TP did not negatively impact liver function in patients with advanced HCC,6\n1668,MANF,M1 PHENOTYPE,Loss of MANF promotes M1 phenotype,6\n506,CLONORCHIS SINENSIS,HEPATOCARCINOGENESIS,C. sinensis infection may contribute to the development of HCC,5\n1667,MANF,TUMOR NEOVASCULARIZATION,Loss of MANF promotes tumor neovascularization,5\n1669,TAMS,M1 PHENOTYPE,TAMs reprogrammed into M1 phenotype,5\n1673,TAM,REPROGRAMMING,TAMs can be reprogrammed for therapeutic purposes,5\n508,CLONORCHIS SINENSIS,947 HCC PATIENTS,The study analyzed 947 patients divided into two groups based on C. sinensis presence,4\n632,OBESITY,LUNG GROWTH,Obesity can impact lung growth after PNX,4\n855,NIR-II IMAGING,VEGFR-TARGETED PROBE,NIR-II imaging is used to characterize HCC-related angiogenesis using a VEGFR-targeted probe,4\n1670,HCC PROGRESSION,HCC PATIENTS,HCC patients experience HCC progression,4\n1671,HCC PROGRESSION,HCC MODEL,HCC model exhibits HCC progression,4\n856,NIR-II IMAGING,LIVER METABOLIC CURVES,NIR-II imaging is used to characterize liver metabolic curves,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "role": "user"}], "parameters": {"model": "gemma2:2b", "frequency_penalty": 0.0, "max_tokens": 2000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0, "response_format": {"type": "json_object"}}}, "key": "chat_create_community_report_58e2fe4326134439707eba3d9b8feed3cdba82923c19c25b2b1865f6ef0bbde7_v2"}